Chemical exposomics in human plasma wasenhanced by an optimizedphospholipid removal step that increased targeted method sensitivitywhile also revealing >13,000 new molecular features by LC-HRMSnon-targetedacquisition. The challenge of chemical exposomics in human plasmais the 1000-foldconcentration gap between endogenous substances and environmentalpollutants. Phospholipids are the major endogenous small moleculesin plasma, thus we validated a chemical exposomics protocol with anoptimized phospholipid-removal step prior to targeted and non-targetedliquid chromatography high-resolution mass spectrometry. Increasedinjection volume with negligible matrix effect permitted sensitivemulticlass targeted analysis of 77 priority analytes; median MLOQ= 0.05 ng/mL for 200 & mu;L plasma.In non-targeted acquisition, mean total signal intensities of non-phospholipidswere enhanced 6-fold in positive (max 28-fold) and 4-fold in negativemode (max 58-fold) compared to a control method without phospholipidremoval. Moreover, 109 and 28% more non-phospholipid molecular featureswere detected by exposomics in positive and negative mode, respectively,allowing new substances to be annotated that were non-detectable withoutphospholipid removal. In individual adult plasma (100 & mu;L, n = 34), 28 analytes were detected and quantified among10 chemical classes, and quantitation of per- and polyfluoroalkylsubstances (PFAS) was externally validated by independent targetedanalysis. Retrospective discovery and semi-quantification of PFAS-precursorswas demonstrated, and widespread fenuron exposure is reported in plasmafor the first time. The new exposomics method is complementary tometabolomics protocols, relies on open science resources, and canbe scaled to support large studies of the exposome.

Chemical exposomes can now be comprehensively measured in human blood, but knowledge of their variability and longitudinal stability is required for robust application in cohort studies. Here, we applied high-resolution chemical exposomics to plasma of 46 adults, each sampled 6 times over 2 years in a multiomic cohort, resulting in 276 individual exposomes. In addition to quantitative analysis of 83 priority target analytes, we discovered and semiquantified substances that have rarely or never been reported in humans, including personal care products, pesticide transformation products, and polymer additives. Hierarchical cluster analysis for 519 confidently annotated substances revealed unique and distinctive coexposures, including clustered pesticides, poly(ethylene glycols), chlorinated phenols, or natural substances from tea and coffee; interactive heatmaps were publicly deposited to support open exploration of the complex (meta)data. Intraclass correlation coefficients (ICC) for all annotated substances demonstrated the relatively low stability of the exposome compared to that of proteome, microbiome, and endogenous small molecules. Implications are that the chemical exposome must be measured more frequently than other omics in longitudinal studies and four longitudinal exposure types are defined that can be considered in study design. In this small cohort, mixed-effect models nevertheless revealed significant associations between testosterone and perfluoroalkyl substances, demonstrating great potential for longitudinal exposomics in precision health research.

Background: The chemical exposome includes exposure to numerous environmental and endogenous molecules, many of which have been linked to reproductive outcomes due to their endocrine-disrupting properties. As several breast cancer risk factors, including age and parity, are related to reproduction, it is imperative to investigate the interplay between such factors and the chemical exposome prior to conducting large scale exposome-based breast cancer studies.

Objective: This pilot study aimed to provide an overview of the chemical exposome in plasma samples from healthy women and identify associations between environmental exposures and three risk factors for breast cancer: age, parity, and age at menarche.

Material and methods: Plasma samples (n = 161), were selected based on reproductive history from 100 women participating in the Northern Sweden Health and Disease Study, between 1987 and 2006. Samples were analyzed by liquid chromatography high-resolution mass spectrometry (LC-HRMS) for 77 priority target analytes including contaminants and hormones, with simultaneous untargeted profiling of the chemical exposome and metabolome. Linear mixed effects models were applied to test associations between risk factors and chemical levels.

Results: Fifty-five target analytes were detected in at least one individual and over 94,000 untargeted features were detected across all samples. Among untargeted features, 430 could be annotated and were broadly classified as environmental (246), endogenous (167) or ambiguous (17). Applying mixed effect models to features detected in at least 70% of the samples (16,778), we found seven targeted analytes (including caffeine and various per- and poly-fluoroalkyl substances) and 38 untargeted features, positively associated with age. The directionality of these associations reversed for parity, decreasing with increasing births. Seven separate targeted analytes were associated with age at menarche.

Significance: This study demonstrates how a comprehensive chemical exposome approach can be used to inform future research prioritization regarding associations between known and unknown substances, reproduction, and breast cancer risk.